A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of a study drug for Oral Suspension in Children and Adolescents (2 to < 18) with Chronic Kidney Disease has been approved at 5 sites in Georgia. AmeRuss will be cooperating with another multinational CRO as a part...
more